Department of Medical Oncology, Vall d’Hebron University Hospital and Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
Cristina Saura*Head Breast Cancer Unit, Vall d’Hebron University Hospital and Principal Investigator Breast Group, Vall d’Hebron Institute of Oncology (VHIO), Passeig Vall d’Hebrón 119-129, 08035 Barcelona, Spain
Mark BowerDepartment of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK
Barbara PistilliDepartment of Medical Oncology, Institute Gustave-Roussy, Villejuif, France
Matteo LambertiniDepartment of Medical Oncology, UOC Clinica di Oncologia Medica, IRCCS Policlinico San Martino Hospital, Genoa, Italy
Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy
Diego OttavianiCancer Division, University College London Hospitals, London, UK
Ailsa LumsdenTranslational Oncology & Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King’s College London, London, UK
Sonia PernasDepartment of Medical Oncology, Catalan Institute of Oncology, L’Hospitalet, Spain
Oncobell Program (IDIBELL), CIBERONC, Hospitalet de Llobregat, Barcelona, Spain
Daniele GeneraliMultidisciplinary Breast Pathology and Translational Research Unit, ASST Cremona, Casalmaggiore, Italy
Elia SeguíDepartment of Medical Oncology, Hospital Clinic, Barcelona, Spain
Gemma ViñasDepartment of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain
Eudald FelipDepartment of Medical Oncology, Catalan Institute of Oncology, Badalona, Spain
Ana SanchezDepartment Medical Oncology, Hospital XII de Octubre, Madrid, Spain
Gianpiero RizzoMedical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
Armando SantoroIRCCS Humanitas Research Hospital, Humanitas Cancer Center, Milan, Italy
Department of Biomedical Sciences, Humanitas University, Milan, Italy
Alessio CortelliniDepartment of Biotechnology and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy
Division of Surgery and Cancer, Hammersmith Hospital, Imperial College London, London, UK
Ylenia PeroneMedical Oncology, Velindre Cancer Centre, Cardiff, UK
John ChesterMedical Oncology, Velindre Cancer Centre, Cardiff, UK
Maria IglesiasDepartment of Oncology, Hospital Universitario Son Llatzer, Palma de Mallorca, Spain
Marta BettiResearch Infrastructure, Research and Innovation Department, Azienda Ospedaliera “SS Antonio e Biagio e Cesare Arrigo”, Alessandria, Italy
Bruno VincenziDepartment of Oncology, University “Campus Bio-Medico”, Rome, Italy
Michela LibertiniMedical Oncology Unit, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy
Francesca MazzoniDepartment of Oncology, Careggi University Hospital, Florence, Italy
Rossana BerardiOncology Clinic, Università Politecnica Delle Marche, Ospedali Riuniti Di Ancona, Ancona, Italy
Annalisa GuidaStruttura Complessa di Oncologia Medica e Traslazionale, Azienda Ospedaliera Santa Maria di Terni, Italy
Rachel WuerstleinDepartment of Gynecology and Obstetrics, Breast Center and Gynecological Cancer Center and CCC Munich, University Hospital Munich, Munich, Germany
Angela LoizidouDepartment of Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Belgium
Rachel SharkeyDepartment of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK
Juan Aguilar CompanyDepartment of Medical Oncology, Vall d’Hebron University Hospital and Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
Department of Infectious Diseases, Vall d’Hebron University Hospital, Barcelona, Spain
Marta MatasDepartment of Oncology, Hospital Althaia Manresa, Barcelona, Spain
Chiara SaggiaDepartment of Translational Medicine, University of Piemonte Orientale, Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy
Myria GalaziCancer Division, University College London Hospitals, London, UK
Uma MukherjeeMedical Oncology, Barts Health NHS Trust, London, UK
Mieke Van HemelrijckTranslational Oncology & Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King’s College London, London, UK
Mar MarinDepartment of Medical Oncology, Catalan Institute of Oncology, L’Hospitalet (Barcelona), Spain
Carla StrinaMultidisciplinary Breast Pathology and Translational Research Unit, ASST Cremona, Casalmaggiore, Italy
Aleix PratDepartment of Medical Oncology, Hospital Clinic, Barcelona, Spain
Translational Genomics and Targeted therapies Group, IDIBAPS, Barcelona, Spain
Helena PlaDepartment of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain
Alexia BertuzziIRCCS Humanitas Research Hospital, Humanitas Cancer Center, Milan, Italy
Department of Biomedical Sciences, Humanitas University, Milan, Italy
Lucia del MastroBreast Unit, IRCCS Policlinico San Martino Hospital, Genoa, Italy
Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy
Giampiero PorzioMedical Oncology Unit, San Salvatore Hospital, L’Aquila, Italy
Thomas Newsom-DavisDepartment of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK
Isabel RuizDepartment of Infectious Diseases, Vall d’Hebron University Hospital, Barcelona, Spain
Marco KrengliDivision of Radiotherapy, Department of Translational Medicine, University of Eastern Piedmont and Hospital “Maggiore della Carità”, Novara, Italy
Neha ChopraCancer Division, University College London Hospitals, London, UK
Margarita RomeoDepartment of Medical Oncology, Catalan Institute of Oncology, Badalona, Spain
Ramon SalazarDepartment of Medical Oncology, Catalan Institute of Oncology, L’Hospitalet (Barcelona), Spain
Oncobell Program (IDIBELL), CIBERONC. Hospitalet de Llobregat, Spain
Ignacio PerezDepartment of Oncology, Hospital Althaia Manresa, Barcelona, Spain
Francesca d’AvanzoDepartment of Translational Medicine, University of Piemonte Orientale, Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy
Manuela MilaniMultidisciplinary Breast Pathology and Translational Research Unit, ASST Cremona, Casalmaggiore, Italy
Fanny PommeretDepartment of Medical Oncology, Institute Gustave-Roussy, Villejuif, France
Marco TucciDepartment of Biomedical Sciences and Human Oncology, University of Bari Aldo Moro, Bari, Italy
Paolo PedrazzoliMedical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
Nadia HarbeckDepartment of Gynecology and Obstetrics, Breast Center and Gynecological Cancer Center and CCC Munich, University Hospital Munich, Munich, Germany
Daniela FerranteDepartment of Translational Medicine, Unit of Medical Statistics, University of Piemonte Orientale and Cancer Epidemiology, CPO Piemonte, Novara, Italy
David J. Pinato†Division of Surgery and Cancer, Hammersmith Hospital, Imperial College London, London, UK
Department of Translational Medicine, University of Piemonte Orientale, Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy
Alessandra Gennari†Department of Translational Medicine, University of Piemonte Orientale, Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy
Department of Surgery and Cancer, Imperial College London, London, UK
on behalf of the OnCovid study group*Both authors contributed equally as first authors.
†Both authors contributed equally as last authors.
Corresponding Author:
留言 (0)